Funded Tech Companies
ILiAD Biotechnologies
Headquartered in New York, ILiAD Biotechnologies raised its funding from RA Capital Management, BNP Paribas and Janus Henderson Investors.
Company Overview
Company Name
ILiAD Biotechnologies
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
230 East 15th St. 1-A
New York, NY 10003
USA
New York, NY 10003
USA
Phone
Website
Email Address
Company Background Information
Overview
ILiAD Biotechnologies (ILiAD) is a clinical stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis. Our lead candidate is BPZE1, a live attenuated pertussis vaccine that is currently in Phase 2 and has successfully completed two Phase 1 human clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/11/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Keith Rubin
Chief Financial Officer
Walter Greenblatt
Chief Operating Officer
Ken Solovay
Controller
James Ramadei
General Manager
Marcel Thalen
Vice President
Stanley Kim
Company Investors
- RA Capital Management
- BNP Paribas
- Janus Henderson Investors
- Knott Partners
- Network-1 Technologies (Corey Horowitz)
- Seedlings Life Science Ventures
- JEMS Venture Capital
- SDS Capital Partners
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs